Company / SG&A per Share
PULSE BIOSCIENCES, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2025
5-year range
$0.37 / $0.75
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
#148 of 156
Health Care
What the data says
Among 156 Health Care companies, PULSE BIOSCIENCES, INC. is in the top 5% for sg&a per share. SG&A per Share has fluctuated over the past 10 years, ranging from $0.31 in FY2016 to $1.17 in FY2018.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of -7.0%.
Increased from $0.37 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 156This company $0.49 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 12.0% year-over-year.
- Ranks #148 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | +12.0% |
| FY2024 | $0.43 | +15.7% |
| FY2023 | $0.37 | -20.2% |
| FY2022 | $0.47 | -37.1% |
| FY2021 | $0.75 | +6.7% |
| FY2020 | $0.70 | -15.3% |
| FY2019 | $0.83 | -29.6% |
| FY2018 | $1.17 | +11.7% |
| FY2017 | $1.05 | +238.7% |
| FY2016 | $0.31 | +44.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026